L-158809

Details

Stereochemistry	ACHIRAL
Molecular Formula	C23H21N7
Molecular Weight	395.4597
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCC1=NC2=C(N=C(C)C=C2C)N1C3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5

InChI

InChIKey=ZXLFZNWBWMYLDB-UHFFFAOYSA-N

InChI=1S/C23H21N7/c1-4-20-25-21-14(2)13-15(3)24-23(21)30(20)17-11-9-16(10-12-17)18-7-5-6-8-19(18)22-26-28-29-27-22/h5-13H,4H2,1-3H3,(H,26,27,28,29)

HIDE SMILES / InChI

Molecular Formula	C23H21N7
Molecular Weight	395.4597
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

PubMed

Title	Date	PubMed
Characterization of the binding of [3H]L-158,809: a new potent and selective nonpeptide angiotensin II receptor (AT1) antagonist radioligand.	1992 Dec	1480133

Substance Class	Chemical Created by `admin` on `Fri Dec 15 18:10:17 GMT 2023` Edited by `admin` on `Fri Dec 15 18:10:17 GMT 2023`
Record UNII	608GM1WHMG
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

L-158809

Common Name

English

3H-IMIDAZO(4,5-B)PYRIDINE, 2-ETHYL-5,7-DIMETHYL-3-(2'-(2H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)-

Systematic Name

English

L-158,809

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID00928896

Created by admin on Fri Dec 15 18:10:17 GMT 2023 , Edited by admin on Fri Dec 15 18:10:17 GMT 2023

PRIMARY

PUBCHEM

123856

Created by admin on Fri Dec 15 18:10:17 GMT 2023 , Edited by admin on Fri Dec 15 18:10:17 GMT 2023

PRIMARY

FDA UNII

608GM1WHMG

Created by admin on Fri Dec 15 18:10:17 GMT 2023 , Edited by admin on Fri Dec 15 18:10:17 GMT 2023

PRIMARY

CAS

135145-96-9

Created by admin on Fri Dec 15 18:10:17 GMT 2023 , Edited by admin on Fri Dec 15 18:10:17 GMT 2023

PRIMARY

Related Record Type Details


					608GM1WHMG

L-158809

ACTIVE MOIETY